(2S)-2-[(quinoline-2-carbonyl)-amino]-succinamic acid

We are (2S)-2-[(quinoline-2-carbonyl)-amino]-succinamic acid CAS:136465-98-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(2S)-2-[(quinoline-2-carbonyl)-amino]-succinamic acid
CAS.NO:136465-98-0
Synonyms:(2S)-2-[(quinoline-2-carbonyl)-amino]-succinamic acid
N-(2-Quinolinylcarbonyl)-L-aspargine
N-(quinolin-2-ylcarbonyl)-L-asparagine
(S)-4-AMINO-4-OXO-2-(QUINOLINE-2-CARBOXAMIDO)BUTANOICACID
N2-(2-quinolinylcarbonyl)-L-asparagine
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 723.3±60.0 °C at 760 mmHg
Molecular Formula C14H13N3O4
Molecular Weight 287.271
Flash Point 391.3±32.9 °C
 
Specification:
Appearance:White to light yellow powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Saquinavir(CAS:127779-20-8).

(2S)-2-[(quinoline-2-carbonyl)-amino]-succinamic acid


Related News: “With early evidence of clinical activity for our off-the-shelf, iPSC-derived NK cell programs, we are excited to lead in bringing next-generation CAR T-cell therapies to patients and plan to submit an IND for FT819 in the first half of 2020.”Ciclobutanocarboxilato de metilo CAS:765-85-5 Any drug or medication is composed of two components.10422-35-2 The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data.N-methyl-N-[(3R,4R)-4-methylpiperidin-3-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine CAS:477600-74-1 INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.At the same time, through years of imitation and advanced technology learning, more and more domestic companies have participated in the field of highly original and characteristic APIs.

Related Products
Product Name
(Z)-2-(2-Aminothiazol-4-yl)-2-(tert-butoxycarbonylmethoxyimino)acetic acid View Details
2-Chloro-1,3-Dimethylimidazolidinium Chloride View Details
2-Bromo-1-(3-nitrophenyl)ethanone View Details
2-chloro-1-fluoro-4-isothiocyanatobenzene manufacturer 4-Amino-6-(2-methyl-2-propanyl)-3-thioxo-3,4-dihydro-1,2,4-triazi n-5(2H)-one manufacturer 2,3,4-Trifluorobromobenzene manufacturer N-(5-Chloro-2-methylphenyl)-3-hydroxynaphthalene-2-carboxamide manufacturer tert-butyl 4-(2-carbamoyl-1-benzofuran-5-yl)piperazine-1-carboxylate manufacturer